Protalix (PLX) Gets $25M Milestone from Pfizer in FDA Approval of ELELYSO as Treatment of Type 1 Gaucher
Go back to Protalix (PLX) Gets $25M Milestone from Pfizer in FDA Approval of ELELYSO as Treatment of Type 1 Gaucher| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.37 +0.10 (4.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.27 | 52 Week High | $1.11 | |||
| Open | $2.29 | 52 Week Low | $0.41 | |||
| Day High | $2.39 | P/E | N/A | |||
| Day Low | $2.20 | EPS | $-0.29 | |||
| Volume | 1,232,754 | |||||
